Lexapro, Escitalopram News

US Pharm . 2009;34 :26-39. Uncertainty is high when it comes to selecting the appropriate antidepressant for patients diagnosed with major depressive disorder , not only because studies have reported no differences in efficacy between agents, but also because only 11% to 30% of patients will reach remission with initial treatment, even after a ...

Your blog is a beacon for me. Thank you for being honest about yourself. Blog powered by TypePad Member since 07/2004 November 16, 2009 MGH Seeking Participants for Two Clinical Trials: Bipolar Disorder in Pregnancy and Treatment of Postpartum Depression Massachusetts General Hospital's Center for Women's MentalHealth is conducting two clinical ...

Lexapro is one of the SSRI antidepressants and was created from Celexa . The generic name of Lexapro is escitalopram, but Lexapro is not currently available in generic form.

According to the Associated Press , a former Milwaukee firefighter served his wife a cup of Lexapro-laced tea this Halloween.

Most patients find that sertraline and escitalopram are more effective and better tolerated than other antidepressants Combined psychotherapy and antidepressants are more effective than either treatment alone for all degrees of depression Sertraline is the best choice for an initial antidepressant because it is available in generic form Drug ...

A COMMON antidepressant combined with an intensive treadmill training program helped people with partial spinal cord injuries walk better and faster, US researchers said on Sunday.

A common antidepressant combined with an intensive treadmill training program helped people with partial spinal cord injuries walk better and faster, U.S. researchers said on Sunday.

Nortriptyline has been found to cause a ten-fold increase in suicidal thoughts in men when compared to its competitor escitalopram.

DETROIT Generic drug maker Caraco Pharmaceutical Labs has announced a settlement agreement with Forest Labs in litigation over an antidepressant.

Caraco Pharmaceutical Laboratories, Ltd. announced that, as part of the previously announced settlement of the legal proceedings related to Lexapro tablets, it closed an Asset Purchase Agreement transaction with Forest Laboratories, Inc.

Aspect Medical Systems , maker of the bispectral index monitor thought to be useful for monitoring anesthesia awareness, has been dealt a devastating blow last year by a study published in NEJM under the title Anesthesia Awareness and the Bispectral Index .

When a depressed person goes for treatment, she doesn't want to wait 8 weeks to learn whether her pills will help her.

Main Category: Depression Also Included In: Mental Health ; Psychology / Psychiatry Article Date: 14 Sep 2009 - 4:00 PDT It is a long, slow slog to treat major depression .

Did you know that as much as some doctors and researchers like to think that medicine is a science, it is very much an art too? You can see that no more clearly than in the decision process doctors use to prescribe a specific psychiatric medication.

Overdose of the selective serotonin reuptake inhibitor escitalopram can cause serotonin toxicity, bradycardia, and QT prolongation, according to a report in the September Annals of Emergency Medicine.

It is a long, slow slog to treat major depression. Many antidepressant medications are available, but no single biomarker or diagnostic test exists to predict which one is right for an individual.

Last week, Gardiner Harris writing for the NY Times noted that the US Senate Special Committee on Aging had made public part of Forest Laboratories' Fiscal Year 2004 Marketing Plan for the drug Lexapro , an anti-depressant. The document is available here .

Forest Labs has done very, very well with Lexapro over the years. They're a comparatively small company, and their collaboration with Lundbeck in the antidepressant field has been the biggest event in their history.

Five months after a regulatory snag pointed to a delay with a partnered chronic obstructive pulmonary disease drug, Forest Laboratories Inc.

Five months after a regulatory snag pointed to a delay with a partnered chronic obstructive pulmonary disease drug, Forest Laboratories Inc.